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Abstract
Introduction: Central sensitization (CS) was first defined in animal studies to be increased nociceptive responsiveness due to
sensitization of neurons in the central nervous system, usually the result of prolonged nociceptive input or a disease state. Recently,
the concept of CS has been adopted in clinical assessments of chronic pain, but its diagnosis in humans has expanded to include
the enhancement of a wide range of nociceptive, sensory, and emotional responses. Many poorly understood pain disorders are
referred to as “central sensitivity syndrome,” a term associated with a broad range of hypervigilant sensory and emotional
responses. Diagnosis often involves a review of medical records and an assessment of behaviour, emotional disposition, and overall
sensitivity of a patient. Obviously, these assessments are unable to directly capture the responsiveness of nociceptive neurons. The
purpose of this review is to ascertain whether self-report questionnaires associated with central sensitization and the diagnosis of
central sensitivity syndrome are associatedwith enhanced nociceptive responses orwhether theymore validlymeasure sensitivity in
a broader sense (ie, including emotional responses).
Methods: Following the PRISMA guidelines, a detailed search of studies that involve the Central Sensitization Inventory or Pain
Sensitivity Questionnaire correlated with either nociceptive sensory tests (quantitative sensory testing) or emotional hypervigilance
(anxiety, depression, stress, etc) will be conducted on MEDLINE, PsychINFO, and Web of Science.
Perspective: The review is expected to synthesize correlations between sensitivity questionnaires and nociceptive or emotional
sensitivity to determine whether these questionnaires reflect a broadened understanding of the term “central sensitization.”
Keywords: Central sensitization, Central Sensitization Inventory, Pain Sensitivity Questionnaire, Quantitative sensory testing,
Emotional sensitization, Nociceptive sensitization
1. Introduction
Central sensitization (CS) is defined by the International Associ-
ation for the Study of Pain as “increased responsiveness of
nociceptive neurons in the central nervous system to either
normal or subthreshold afferent input.”8 This definition was
derived from animal studies that explore hypersensitivity to
stimuli,10 greater responsiveness to non-noxious stimuli,12 and
increased pain response evoked by stimuli outside the area of
injury.4,10,12 It has been linked with a multitude of chronic pain
disorders in humans.9,11,15,24,26,34 The association between CS
and chronic pain seems to includemultiple mechanisms involving
spinal cord hyperexcitability21 and ascending or descending
modulatory systems.29 As of yet, there is no conclusivemethod of
establishing the presence of CS in humans, although quantitative
sensory testing (QST) is used to assess the dynamic modulation
of nociceptive signals, which can suggest the presence of CS.3
Although QST allows for a comprehensive assessment of pain
sensitivity profiles, it often involves select training, expensive laboratory
equipment, and sufficient time where the patient’s presence is
required in the laboratory which makes testing difficult at a clinical
level.23 Self-report questionnaireswouldmake a pragmatic alternative
assessment of CS in clinics, allowing for quick and convenient
assessment at little cost. To serve this purpose, however, these
questionnaires would need to demonstrate acceptable associations
with known measures of CS to show sufficient construct validity.
Two such self-report questionnaires that are widely used in the
assessment of CS and pain sensitivity are the Central Sensitisation
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Inventory (CSI) and the Pain Sensitivity Questionnaire (PSQ). The
CSI was designed to identify patients who have symptoms that
may be related to CS or central sensitivity syndromes (CSSs), such
as fibromyalgia, neck injury, temporomandibular joint disorder, or
migraine or tension headaches.19 It has been shown to bea reliable
and valid psychometric instrument for identifying individuals
vulnerable to pain.13
One question that arises regarding the inventory, however, is
the degree to which it reflects CS as defined by the animal
literature, ie, increased summation of nociception, reduced
inhibition of pain, hypervigilance to noxious and non-noxious
stimuli (allodynia or hyperalgesia), and widespread pain sensitiv-
ity.10,31,32 Instead, the questionnaire seems to focus more on
hypersensitivity in a broader sense including feelings of anxiety
and depression, as well as cognitive impairment. If this is the
case, it may contribute to a broadening usage of the term “central
sensitization” to include particular psychological profiles rather
than simply centrally enhanced nociceptive responsivity.
Central sensitivity syndrome (CSS) is a recently developed
diagnosis for several pain conditions,33 which may embody this
construct drift. Central sensitivity syndrome describes a group of
medically unexplained disorders (eg, fibromyalgia or chronic
fatigue) for which CS may be a common underlying cause.
Because of the difficulty of directly assessing the presence of CS
in humans, the diagnosis of CSS includes a focused review of
medical records, interviewing techniques, and observations of
pain and emotional behaviour, mental fog, drug and food
intolerance, psychiatric disorders, and trauma.5 The CSI was
developed as a self-report screening instrument to help identify
patients with CSS.13,19 Although this measure has demonstrated
clinical utility13,19 in identifying individuals vulnerable to pain, a
question remains as to whether this diagnostic tool truly reflects
the traditional understanding of “central sensitization” as por-
trayed by early animal studies10: increased responsiveness of
nociceptive neurons in the central nervous system. We are
interested in exploring the extent to which “central sensitivity
syndromes,” diagnosed using the CSI, may not truly represent
the CS mechanism derived from preclinical animal studies. A
diagnosis of CSS gives a central mechanism to legitimize a
patient’s pain and therefore may have clinical value, yet this
diagnosis may not truly be representative of the canonical
(preclinical) mechanism of CS as the questionnaires title would
suggest. Instead, the questionnaire may reflect a broader
definition of sensitivity which includes depression, anxiety, stress,
and neuroticism.
The PSQ may more directly measure the sensory facilitation
involved in CS.25 It focuses more on respondents imagining
situations that involve nociceptive input and predicting how they
would react. The questions are posed to measure sensitization to
sensory input, but the degree to which it reflects a top-down
component influenced by personality type or disposition remains
open. More specifically, whether it reflects these psychological
profiles to the same degree as the CSI is a germane question for
understanding how closely related and psychometrically distinct
these measures are.
In this review, we aim to evaluate the degree to which
measures of nociceptive sensitization (eg, quantitative sensory
measures) correspond to these sensitivity questionnaires (CSI
and PSQ) and how strongly they are influenced by psychological
factors. If the latter is a strong determinant of scores on these
measures, inferring “central sensitization” on the basis of such
scores would represent a broadening of the definition of CS
(construct drift) to include hypersensitivity to psychological states
such as depression and anxiety. If this were the case, it might
necessitate reconsideration of what is meant by the term “central
sensitization” in clinical contexts and perhaps questioning of the
presumption of a specific physiological mechanism on the basis
of such measures.
2. Objective
The objective of this overview is to review the available studies
that examined the association between questionnaires putatively
measuring CS (the PSQ or CSI) against quantitative sensory
measures and psychological questionnaires. In doing so, we aim
to assess and compare the 2 questionnaires in the degree to
which they assess nociceptive sensitization or emotional
sensitization. Our main aim is to assess whether the CSI is likely
to reflect responsiveness of nociceptive neurons or whether it
assesses sensitization in a broader context. We are also
interested to assess whether the PSQ more accurately maps
on to the preclinical definition of CS.
2.1. Hypotheses
Given the nature of the questions posed in the CSI and PSQ, we
expect that the CSI will be strongly correlated with psychological
constructs such as depression, anxiety, stress, and neurotic
behaviour. As the PSQ focuses on questions related to pain
sensitivity, we expect the PSQ to be more strongly map on to
measures of nociceptive stimulation (thermal, pressure, and
electrical) such as pain thresholds, pain tolerance, and temporal
summation. We are also interested in exploring the extent to
which self-report questionnaires may reflect descending aspects
of modulation (impaired inhibition), therefore including CPM as a
measure of interest.
3. Methods
This protocol is developed in accordance with the PRISMA-P
guidelines16 and is registered in the PROSPERO register
(CRD42021208731).
3.1. Sources of evidence
We will conduct a detailed search on MEDLINE, PsychINFO, and
Web of Science from their inception until the date of the search.
Two separate searches will be conducted (see search terms in
section below), and some results are expected to overlap
(duplicates will be removed). Both searches will include the CSI
or the PSQ. One search will review the CSI or PSQ for sensory
correlates (eg, QSTmeasures), and the second search will review
their correlations with psychological questionnaires (eg, anxiety,
depression, pain catastrophising, etc) as well as any personality
questionnaires that suggest neurotic behaviour. We are specif-
ically interested in neuroticism given the evidence that it is related
to pain sensitivity20 but have cast a broader scope to examine
whether other personality factors are relevant. We will also review
the bibliographies of any relevant study identified and search
Google Scholar to identify any additional published articles.
3.2. Search terms
3.2.1. Search 1 terms
“Quantitative sensory testing” or “wind-up”or “temporal summation”
or “conditionedpainmodulation” or “pain threshold” or “pain ratings”
or “hyperalgesia” or “allodynia” or “offset analgesia” or “widespread
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pain” or “pain tolerance” or “evoked pain” or “experimental pain”
AND “central sensitization inventory” or “CSI” or “PSQ.”
3.2.2. Search 2 terms
“Depression” or “anxiety” or “stress” or “catastrophizing” or
“rumination” or “neuroticism” or “personality” or “abuse” or
“trauma” AND “central sensitization inventory” or “CSI” or “PSQ.”
3.3. Inclusion criteria
Studies eligible for inclusion in the reviewwill include human studies
only. They must be written in English andmust be an original peer-
reviewed experiment (ie, not a dissertation, case study, or review
article). Finally, studies must include at least one of the CSI or PSQ
instruments. The CSI or PSQ must be correlated against at least 1
psychological or sensory measure of interest.
3.4. Report selection
3.4.1. Types of studies
The review will include studies that correlate the PSQ or CSI with
sensory or psychological measures. In studies that involve an
intervention, measures will only be considered if they were
assessed before the intervention.
3.4.2. Types of participants
Wewill include studies with participants of all ages. Healthy subjects
as well as studies involving patients with chronic pain will be
included.Where comparative studies are available, we will compare
the findings for patients with pain against healthy controls.
3.5. Data collection, extraction, and management
Two independent reviewers will assess studies for eligibility.
Initially, titles and abstracts will be screened, and full-text
screening will be performed on citations believed to be potentially
eligible. Any discrepancies between the reviewers will be resolved
by discussion and consensus. A third reviewerwill be consulted in
cases of disagreement.
One reviewer will extract relevant data from each study (r co-
efficient and P value). If these values are not given within the
article, authors will be contacted to provide the relevant
correlation co-efficient and P values. The second reviewer will
check the extracted data.
3.6. Outcome measures
Our primary outcomes will include the CSI or the PSQ correlated
with sensory measures associated with CS. These include QST
measures, temporal summation, conditioned pain modulation,
pain thresholds and tolerance, and any measure related to
nociceptive hypersensitivity or widespread pain.
The second primary outcome measure will include the CSI or
the PSQ correlated with psychological factors associated with
CS. These include questionnaires that assess depression,
anxiety, stress, pain catastrophizing, abuse, trauma, mindful-
ness, neuroticism or personality, and any other measure related
to emotional hypersensitivity. In studies that report trait and state
levels for a construct, ie, the state-trait anxiety questionnaire, we
will try to differentiate between the 2 levels if our search finds
enough data tomake analysis of this distinction reliable. However,
given that these measures have high intercorrelation,22 we will
collapse scores into an average correlation score for that
construct if there are not sufficient data.
3.7. Analysis plan
3.7.1. Analysis of outcomes
Meta-analyses will be conducted for CSI correlations with
psychological constructs such as depression, anxiety, or
catastrophising when measures of the same construct (eg,
different anxiety questionnaires) are judged to be similar enough
to support valid conclusions.
Meta-analyses for quantitative sensory measures will also be
conducted by analysing each measure separately: Pressure pain
threshold, heat pain threshold, conditioned pain modulation,
temporal summation, etc will be separately meta-analysed against
CSI. Any other findings with insufficient data for ameta-analysis will
be presented as a narrative review with a descriptive analysis.
The same meta-analyses will be conducted for the PSQ.
Assessing the 2 questionnaires (the CSI and PSQ) for what
correlations they map on to will allow us to assess what these
questionnaires are measuring. Comparing the 2 questionnaires
against each other will allow us to make relative comparisons
accounting for mono-method bias (ie, will both questionnaires be
strongly correlated with psychological measures as they are both
largely based on self-reports?). We will test to see whether the
correlations are significantly different and therefore will be able to
assess whether one questionnaire more strongly correlates with
emotional sensitization and whether the other is a more valid
measure of nociceptive sensitization.
3.7.2. Analysis of risk of bias
A modified version of the quality appraisal process proposed by
Hayden et al.7 will be conducted by 2 independent authors to
evaluate potential sources of bias across 5 domains: participation
bias, publication bias, attrition, methodological quality, and
statistical analysis. We will assess the following for each study:
(1) Were potential sources of participation bias considered and
addressed? (2) Was there any missing data regarding the
variables of interest? (3) Was the methodology of the variable of
interest of a standardized quality? (4) Was the desirable statistical
analyses performed? (5) Was the sample size adequate? Each
category will be assigned a low, unclear, or high risk of bias and
presented with a “risk of bias” summary. Disagreements between
reviewers will be resolved with discussion and consensus. If
necessary, a third reviewer will be consulted.
3.7.3. Analysis of participation bias
Specific sources of participation bias will be identified, ie, age and
sex characteristics of the population sample, as well as
population samples that excluded participants based on mental
health, physical health, or medication being taken.
4. Discussion
We will assess whether self-report questionnaires (the CSI and
PSQ) which are widely considered to bemeasures of CS primarily
reflect enhanced responsiveness to nociception or a broader
construct including maladaptive emotional responsivity. We will
do so by comparing correlations between these questionnaires
and nociceptive responsivity on one hand and emotional
6 (2021) e962 www.painreportsonline.com 3
sensitization on the other. Both questionnaires have demon-
strated clinical utility in identifying pain vulnerability,19,30 but if they
largely reflect psychological states such as anxiety, depression,
and catastrophizing, their use as measures of CS may reflect a
broadening of our definition of that construct.
We know that sensitization to nociception is associated with
increased vulnerability to other disorders of the central nervous
system such as depression, anxiety, and stress.1,6,14,17,27,28
Psychological distress and sensitization to nociception have a
bidirectional influence on each other.2 Assessments of CS,
particularly the CSI, seem to have used this strong association to
help determine characteristics of CS syndromes.18,19 Although
these assessments serve great utility in a diagnostic sense, we
would like to explore the extent to which these questionnaires
truly assess “increased responsiveness of nociceptive neurons in
the central nervous system to either normal or subthreshold
afferent input”8 and clarify that these 2 constructs of hypervig-
ilance (nociceptive and psychological), while strongly related, are
dissociable and therefore not best treated as a single construct.
Doing so runs the risk of presuming a specific (but untested)
physiological mechanism whenever a particular psychological
profile is present. As such, it motivates us to understand exactly
what these measures are examining.
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